+ND Capital — 2012 Investments
1 investments dated 2012 · listed companies and verified rows first · show all
Tarveda TherapeuticsinSeries A · Jan 2012 · $3M
BiotechWatertown, US
Omid Farokhzad(Director)inRobert S. Langer, Jr.(Director)Omid C. Farokhzad(Director)inRobert S. Langer(Director)Andrew J. Fromkin(Executive Officer, Director)Leila Alland(Executive Officer)in
Co-investorsKendall Capital PartnersNew Enterprise Associates (NEA)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.